Sfoglia per Autore
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
2011 F. Marabita, A.M. Aghemo, S. De Nicola, M. Rumi, C. Cheroni, R. Scavelli, M. Crimi, R.M. Soffredini, S. Abrignani, R. De Francesco, M. Colombo
Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity
2012 A. Bianco, V. Reghellin, L. Donnici, S. Fenu, R. Alvarez, C. Baruffa, F. Peri, M. Pagani, S. Abrignani, P. Neddermann, R. de Francesco
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
2012 S. De Nicola, A. Aghemo, M. Rumi, E. Galmozzi, L. Valenti, R. Soffredini, R. De Francesco, G. Prati, R. D'Ambrosio, C. Cheroni, M.F. Donato, M. Colombo
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis
2012 C. Zingaretti, M. Arigò, A. Cardaci, M. Moro, M. Crosti, A. Sinisi, E. Sugliano, C. Cheroni, F. Marabita, R. Nogarotto, R.J.P. Bonnal, P. Marcatili, M. Marconi, A. Zignego, P. Muratori, P. Invernizzi, P. Colombatto, M. Brunetto, F. Bonino, R. De Francesco, J. Geginat, M. Pagani, L. Muratori, S. Abrignani, M. Bombaci
New horizons in hepatitis C antiviral therapy with direct-acting antivirals
2013 A. Aghemo, R. De Francesco
Hepatitis C virus-specific directly acting antiviral drugs
2013 L. Delang, J. Neyts, I. Vliegen, S. Abrignani, P. Neddermann, R. De Francesco
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
2013 P. Lampertico, M. Viganò, C. Cheroni, F. Facchetti, F. Invernizzi, V. Valveri, R.M. Soffredini, S. Abrignani, R. De Francesco, M.G. Colombo
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients
2013 A. Aghemo, E. Degasperi, M.G. Rumi, E. Galmozzi, L. Valenti, R. De Francesco, S. De Nicola, C. Cheroni, E. Grassi, M. Colombo
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
2013 G. Nizzoli, J. Krietsch, A. Weick, S. Steinfelder, F. Facciotti, P. Gruarin, A. Bianco, B. Steckel, M. Moro, M. Crosti, C. Romagnani, K. Stölzel, S. Torretta, L. Pignataro, C. Scheibenbogen, P. Neddermann, R. De Francesco, S. Abrignani, J. Geginat
Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients
2014 E. Degasperi, L. Valenti, A. Aghemo, R. De Francesco, M. Rumi, R. Soffredini, L. Donnici, C. Cheroni, S. Fargion, V. Zanoni, E. Orsi, M. Colombo
Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material
2014 C. Vassena, S. Fenu, F. Giuliani, L. Fantetti, G. Roncucci, G. Simonutti, C.L. Romanò, R. De Francesco, L. Drago
Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking
2014 H. Wang, J.W. Perry, A.S. Lauring, P. Neddermann, R. De Francesco, A.W. Tai
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent
2014 R. D'Ambrosio, A. Aghemo, R. De Francesco, M.G. Rumi, E. Galmozzi, S. De Nicola, C. Cheroni, P.J. Clark, G. Ronchi, P. Lampertico, M. Colombo
Why is it so difficult to develop a hepatitis C virus preventive vaccine?
2014 C. Zingaretti, R. De Francesco, S. Abrignani
In vitro antibiofilm activity of bioactive glass S53P4
2014 L. Drago, C. Vassena, S. Fenu, E. De Vecchi, V. Signori, R.D. Francesco, C.L. Romanò, R. DE FRANCESCO
Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors
2014 D.R. Mcgivern, T. Masaki, S. Williford, P. Ingravallo, Z. Feng, F. Lahser, E. Asante-Appiah, P. Neddermann, R. De Francesco, A.Y. Howe, S.M. Lemon
Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C
2014 S. De Nicola, P. Dongiovanni, A. Aghemo, C. Cheroni, R. D'Ambrosio, M. Pedrazzini, F. Marabita, L. Donnici, M. Maggioni, S. Fargion, M. Colombo, R. De Francesco, L. Valenti
NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase III∝ complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes
2014 V. Reghellin, L. Donnici, S. Fenu, V. Berno, V. Calabrese, M. Pagani, S. Abrignani, F. Peri, R.D. Francesco, P. Neddermann
Hepatitis C virus deletion mutants are found in individuals chronically infected with genotype 1 hepatitis c virus in association with age, high viral load and liver inflammatory activity
2015 C. Cheroni, L. Donnici, A. Aghemo, F. Balistreri, A. Bianco, V. Zanoni, M. Pagani, R. Soffredini, R. D'Ambrosio, M.G. Rumi, M. Colombo, S. Abrignani, P. Neddermann, R. De Francesco
The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4
2015 V. Ranzani, G. Rossetti, I. Panzeri, A. Arrigoni, R. Bonnal, S. Curti, P. Gruarin, E. Provasi, E. Sugliano, M. Marconi, R. De Francesco, J. Geginat, B. Bodega, S. Abrignani, M. Pagani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile